Results 291 to 300 of about 292,142 (337)
Some of the next articles are maybe not open access.
Journal of Substance Abuse Treatment, 2022
INTRODUCTION Clinical guidelines strongly recommend opioid agonist treatment (OAT) as first-line treatment for opioid use disorder (OUD). However, racial/ethnic minoritized patients are less likely to receive OAT compared to non-Hispanic White patients ...
Jawad M Husain +5 more
semanticscholar +1 more source
INTRODUCTION Clinical guidelines strongly recommend opioid agonist treatment (OAT) as first-line treatment for opioid use disorder (OUD). However, racial/ethnic minoritized patients are less likely to receive OAT compared to non-Hispanic White patients ...
Jawad M Husain +5 more
semanticscholar +1 more source
Pharmacological treatment for depression during opioid agonist treatment for opioid dependence
Cochrane Database of Systematic Reviews, 2010Lifetime prevalence of depression in subjects with opioid dependence is higher than in the general population (44-54% versus 16%) and represents a risk factor for morbidity and mortality. For patients on opioid agonist treatment, current prevalence rates of depression ranges between 10 and 30%, influencing negatively the outcome of the treatment.To ...
Pier Paolo, Pani +4 more
openaire +2 more sources
Opioid Agonist Treatment Modifications During COVID‐19 Pandemic
Drug and Alcohol DependenceBeth Sproule +6 more
openaire +2 more sources
Agonist treatment in opioid use: Advances and controversy
Asian Journal of Psychiatry, 2012Opioid dependence is a chronic relapsing condition which requires comprehensive care; pharmacological agents form the mainstay of its long term treatment. The two most popular approaches are the harm reduction method using agonists and the complete abstinence method using antagonists.
Biju, Viswanath +3 more
openaire +2 more sources
Drug and Alcohol Dependence, 2021
BACKGROUND Given the elevated risk of mortality immediately following opioid agonist treatment (OAT) discontinuation, determining the frequency and timing of OAT discontinuation can help guide the planning of services to facilitate uninterrupted OAT.
E. Krebs +6 more
semanticscholar +1 more source
BACKGROUND Given the elevated risk of mortality immediately following opioid agonist treatment (OAT) discontinuation, determining the frequency and timing of OAT discontinuation can help guide the planning of services to facilitate uninterrupted OAT.
E. Krebs +6 more
semanticscholar +1 more source
Opioid Agonist Treatment Recipients within Criminal Justice-Involved Populations
Substance Use & Misuse, 2022Background: In 2014, nearly 2.5 million Americans had a substance use disorder for opioids (e.g., prescription pain medication or heroin) with over half estimated to have had prior contact with the criminal justice system. Despite strong evidence that opioid agonist treatment (OAT) is effective in reducing overdose, increasing treatment retention, and ...
Wendy P. Guastaferro +3 more
openaire +2 more sources
Addiction, 2021
BACKGROUND AND AIM Effective policies to reduce drug-related overdoses remain a public health priority. We aimed to estimate the causal effects of a national opioid agonist treatment (OAT) program on population level drug fatalities.
O. Røgeberg +2 more
semanticscholar +1 more source
BACKGROUND AND AIM Effective policies to reduce drug-related overdoses remain a public health priority. We aimed to estimate the causal effects of a national opioid agonist treatment (OAT) program on population level drug fatalities.
O. Røgeberg +2 more
semanticscholar +1 more source
Journal of Substance Abuse Treatment, 2014
The New Jersey Medication Assisted Treatment Initiative (NJ-MATI) sought to reduce barriers to treatment by providing free, opioid agonist treatment (OAT, methadone or buprenorphine) via mobile medication units (MMUs). To evaluate barriers to OAT, logistic regression was used to compare opioid dependent patients enrolled in NJ-MATI to those entering ...
Gerod, Hall +9 more
openaire +2 more sources
The New Jersey Medication Assisted Treatment Initiative (NJ-MATI) sought to reduce barriers to treatment by providing free, opioid agonist treatment (OAT, methadone or buprenorphine) via mobile medication units (MMUs). To evaluate barriers to OAT, logistic regression was used to compare opioid dependent patients enrolled in NJ-MATI to those entering ...
Gerod, Hall +9 more
openaire +2 more sources
Nasal Opioid Agonist Treatment in Patients with Severe Opioid Dependence: A Case Series
European Addiction Research, 2021<b><i>Introduction:</i></b> Opioid agonist treatment (OAT) is the first-line treatment for opioid dependence. Currently available OAT options comprise oral (methadone and morphine) and sublingual (buprenorphine) routes of administration.
Marc, Vogel +9 more
openaire +2 more sources
Epidemiology, 2021
Supplemental Digital Content is available in the text. Background: Studies of people who inject drugs (PWID) commonly use questionnaires to determine whether participants are currently, or have recently been, on opioid agonist treatment for opioid use ...
Z. Bouck +8 more
semanticscholar +1 more source
Supplemental Digital Content is available in the text. Background: Studies of people who inject drugs (PWID) commonly use questionnaires to determine whether participants are currently, or have recently been, on opioid agonist treatment for opioid use ...
Z. Bouck +8 more
semanticscholar +1 more source